Krakhmal N V, Vasilchenko D V, Vtorushin S V
Siberian State Medical University, Tomsk, Russia.
Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia.
Arkh Patol. 2022;84(6):61-66. doi: 10.17116/patol20228406161.
Lafora disease is a rare hereditary genetic pathology of the nervous system (a group of progressive myoclonic epilepsies). The distinctive morphological feature of this disease is the presence of specific abnormal structures - polyglucosane bodies («Lafora bodies») in the brain tissue, myocardium, liver, and epithelium of the sweat gland ducts. The article discusses the clinical data of the course of Lafora's disease in an 18-year-old patient with a fatal outcome and the results of a post-mortem examination. The diagnosis of Lafora disease was confirmed by genetic analysis data - the presence of a homozygous mutation in the 2nd exon of the gene - laforin (chr6:146007412G>A, rs137852915). When analyzing literature, we did not find a description of Lafora's disease cases with a fatal outcome with the presentation of macroscopic examination data at autopsy, as well as the results of a pathohistological examination of altered organ tissues with the morphological manifestations specific for this pathology (Lafora bodies in the the brain, heart, sweat gland epithelium).
拉福拉病是一种罕见的遗传性神经系统基因病理学疾病(一组进行性肌阵挛性癫痫)。该疾病独特的形态学特征是在脑组织、心肌、肝脏和汗腺导管上皮中存在特定的异常结构——多聚葡糖体(“拉福拉小体”)。本文讨论了一名18岁拉福拉病患者的临床病程资料及死亡结局,以及尸检结果。基因分析数据证实了拉福拉病的诊断——基因laforin的第2外显子存在纯合突变(chr6:146007412G>A,rs137852915)。在分析文献时,我们未发现有关于拉福拉病死亡病例的描述,包括尸检时的大体检查数据,以及对病变器官组织进行病理组织学检查的结果,这些结果具有该病理学特有的形态学表现(脑、心脏、汗腺上皮中的拉福拉小体)。